The FDA granted Priority Review to lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP). Lenacapavir is a long-acting HIV-1 capsid inhibitor administered as a twice-yearly ...

Leukemia cutis is a rare form of leukemia that causes skin lesions. The appearance of the lesions varies significantly from person to person. Lesions may appear as small or large lumps ...

The Bullous Pemphigoid Disease Area Index (BPDAI ... For patients who have only skin lesions and are not suitable for traditional corticosteroids and immunosuppressive therapy due to underlying ...

(A) Tense vesiculobullous lesions in the palmar region in an adult patient with linear IgA bullous dermatosis. (B) Erosions and tense bullous lesions on the oral mucosa of an adult patient with linear ...

Variables with the corresponding odds ratios and confidence intervals are shown in the figure.SARS-CoV-2, acute respiratory syndrome coronavirus 2; BP, bullous pemphigoid; COVID-19, coronavirus ...

and bullous pemphigus. Vasculitic urticaria, a rare condition often associated with autoimmune phenomena, presents with recurrent skin lesions resembling chronic urticaria but persisting beyond 24 ...

Survey results indicated that cutaneous lupus erythematosus (CLE) significantly affects quality of life (QOL) independently and additively in patients with systemic lupus erythematosus (SLE), with ...

Dupilumab is now approved for CSU patients aged 12+ not controlled by H1 antihistamines, targeting IL-4 and IL-13 pathways. Phase 3 trials showed significant reductions in itch and urticaria ...

A recent case report explains how epitope spread may cause immune checkpoint inhibitor (ICI)–associated bullous pemphigoid (BP). A separate research letter spotlights cases of partial ...

In 2020, Nyati was diagnosed with a parasitic infection that, despite successful treatment, caused permanent lesions that continued to depredate her brain. "Though your body may have slowed you ...